220 related articles for article (PubMed ID: 17010739)
1. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis.
Brown KK; Rehmus WE; Kimball AB
J Am Acad Dermatol; 2006 Oct; 55(4):607-13. PubMed ID: 17010739
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of patient adherence to topical treatments: 95% of patients underdose.
Storm A; Benfeldt E; Andersen SE; Serup J
J Am Acad Dermatol; 2008 Dec; 59(6):975-80. PubMed ID: 18817998
[TBL] [Abstract][Full Text] [Related]
3. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use.
Carroll CL; Feldman SR; Camacho FT; Manuel JC; Balkrishnan R
J Am Acad Dermatol; 2004 Aug; 51(2):212-6. PubMed ID: 15280839
[TBL] [Abstract][Full Text] [Related]
4. Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence.
Williams LK; Joseph CL; Peterson EL; Wells K; Wang M; Chowdhry VK; Walsh M; Campbell J; Rand CS; Apter AJ; Lanfear DE; Tunceli K; Pladevall M
J Allergy Clin Immunol; 2007 Nov; 120(5):1153-9. PubMed ID: 17936894
[TBL] [Abstract][Full Text] [Related]
5. Are ointments better than other vehicles for corticosteroid treatment of psoriasis?
Zivkovich AH; Feldman SR
J Drugs Dermatol; 2009 Jun; 8(6):570-2. PubMed ID: 19537382
[TBL] [Abstract][Full Text] [Related]
6. Patients' educational needs about topical treatments for psoriasis.
Martin SL; McGoey ST; Bebo BF; Feldman SR
J Am Acad Dermatol; 2013 Jun; 68(6):e163-8. PubMed ID: 22682885
[TBL] [Abstract][Full Text] [Related]
7. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.
van de Kerkhof PC; Kragballe K; Segaert S; Lebwohl M;
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1130-9. PubMed ID: 21564329
[TBL] [Abstract][Full Text] [Related]
8. Class I topical corticosteroid use by psoriasis patients in an academic practice.
Pearce DJ; Spencer L; Hu J; Balkrishnan R; Fleischer AB; Feldman SR
J Dermatolog Treat; 2004 Jul; 15(4):235-8. PubMed ID: 15764038
[TBL] [Abstract][Full Text] [Related]
9. Disease burden and treatment adherence in psoriasis patients.
Feldman SR
Cutis; 2013 Nov; 92(5):258-63. PubMed ID: 24343214
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis treatment in the United States at the end of the 20th century.
Pearce DJ; Stealey KH; Balkrishnan R; Fleischer AB; Feldman SR
Int J Dermatol; 2006 Apr; 45(4):370-4. PubMed ID: 16650160
[TBL] [Abstract][Full Text] [Related]
11. Patient nonadherence to medication in inflammatory bowel disease.
Sewitch MJ; Abrahamowicz M; Barkun A; Bitton A; Wild GE; Cohen A; Dobkin PL
Am J Gastroenterol; 2003 Jul; 98(7):1535-44. PubMed ID: 12873575
[TBL] [Abstract][Full Text] [Related]
12. Adherence to acitretin and home narrowband ultraviolet B phototherapy in patients with psoriasis.
Yentzer BA; Yelverton CB; Pearce DJ; Camacho FT; Makhzoumi Z; Clark A; Boles A; Fleischer AB; Balkrishnan R; Feldman SR
J Am Acad Dermatol; 2008 Oct; 59(4):577-81. PubMed ID: 18619709
[TBL] [Abstract][Full Text] [Related]
13. Topical corticosteroids in psoriasis: strategies for improving safety.
Horn EJ; Domm S; Katz HI; Lebwohl M; Mrowietz U; Kragballe K;
J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):119-24. PubMed ID: 20175860
[TBL] [Abstract][Full Text] [Related]
14. [Topical treatment adherence for psoriasis].
Halioua B
Rev Prat; 2012 Feb; 62(2):156-9. PubMed ID: 22408849
[No Abstract] [Full Text] [Related]
15. Relationships between multiple self-reported nonadherence measures and pharmacy records.
Rickles NM; Svarstad BL
Res Social Adm Pharm; 2007 Dec; 3(4):363-77. PubMed ID: 18082873
[TBL] [Abstract][Full Text] [Related]
16. [Adherence of local (and general) treatments in psoriasis].
Cribier B
Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S13-7. PubMed ID: 22305281
[TBL] [Abstract][Full Text] [Related]
17. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
18. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
[TBL] [Abstract][Full Text] [Related]
19. Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation.
Chan CS; Van Voorhees AS; Lebwohl MG; Korman NJ; Young M; Bebo BF; Kalb RE; Hsu S
J Am Acad Dermatol; 2009 Jun; 60(6):962-71. PubMed ID: 19375191
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoeconomic model of topical treatment options of mild to moderate psoriasis vulgaris in Germany.
Augustin M; Radtke M; van Engen A; Ruedig C; Lapp C; Moehling U
J Dtsch Dermatol Ges; 2009 Apr; 7(4):329-38. PubMed ID: 19243481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
